These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recent advances in therapy for glioblastoma. Clarke J; Butowski N; Chang S Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224 [TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme: a review of where we have been and where we are going. Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for inhibiting invasion in glioblastoma. Drappatz J; Norden AD; Wen PY Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303 [TBL] [Abstract][Full Text] [Related]
11. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme. Parvez T Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496 [TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114 [TBL] [Abstract][Full Text] [Related]
14. Cure following gene therapy for recurrent glioblastoma multiforme? Karabatsou K; Bernstein M Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival with glioblastoma multiforme. Krex D; Klink B; Hartmann C; von Deimling A; Pietsch T; Simon M; Sabel M; Steinbach JP; Heese O; Reifenberger G; Weller M; Schackert G; Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346 [TBL] [Abstract][Full Text] [Related]
16. [Glioblastomas: clinical study and search for prognostic factors]. Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806 [TBL] [Abstract][Full Text] [Related]
17. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for glioblastoma. Aghi M; Chiocca EA Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633 [TBL] [Abstract][Full Text] [Related]